About Event
The Only Dedicated Forum for CGT Supply Chain Industry Professionals
The successful delivery of cell and gene therapies (CGTs) hinges on the development of scalable and resilient supply chains that can meet difficult logistical requirements, temperature controls, and import-export compliance. Achieving success requires a collaborative and efficient multistakeholder approach across multiple departments, manufacturing sites, and external partners.
At the Supply Chain & Logistics for Cell & Gene Therapies Summit attendees gained unparalleled insights and case studies from these different stakeholders into how they optimize and deploy their supply chains globally, whether these are being applied to autologous or allogenic cell therapies, or in vivo or ex vivo gene therapy programs.
2025's meeting explored the full end-to-end supply chain, with the likes of J&J, ArsenalBio, Novartis, REGENXBIO, and Beam Therapeutics providing attendees actionable insights to:
Scale Up to P1, Pivotal Study & Commercialization
Managing volatile supplies of materials and manufacturing slots, transition quickly into new regions, and develop and sustain a commercial-ready supply chain
Master the
Digitalization Process
Exploring solutions that capture both patient and product journeys, ensuring system integration across all chain-of-identity (COI) and custody (COC) activities, as well as manufacturing planning and scheduling
Collaborate Effectively with Stakeholders
Simplifying processes between different partners, navigate the complexity of last-mile logistics, and discover what good collaboration looks like with clinical ops departments
Expand Compliantly into New Regions
Outlining COI and COC requirements for different global regions, identify suitable shipping lanes and storage facilities, onboard new external partners, and establish compliant labeling practices
Drive Standardization Efforts
Exploring the latest initiatives in driving standardization in labeling, apheresis collection, and treatment center management, and brainstorm solutions to the lack of cross-industry harmonization
2025's Event in Numbers
70+
Attendees
50+
Companies
21
Expert Speakers
12
New Speaking Companies
5
Commercial-Stage
Speaking Companies
100%
Alignment with Supply Chain Developments
Who Would You Have Met?
The Supply Chain & Logistics for Cell & Gene Therapies Summit is dedicated to progressing the supply chain field by fostering collaboration. We attract an audience of industry experts to ignite thought-provoking discussions that lead to long-term, mutually beneficial relationships in a rapidly evolving field.
This is the only industry-led forum dedicated to harmonizing, streamlining, and scaling up processes for CGT supply chains.
